Full statement from IFT: http://www.itftennis.com/news/231175.aspx8 June 2016 – London, ENGLAND - An Independent Tribunal appointed under Article 8.1 of the 2016 Tennis Anti-Doping Programme (the "Programme") has found that Maria Sharapova committed an Anti-Doping Rule Violation under Article 2.1 of the Programme and as a consequence has disqualified the affected results and imposed a period of ineligibility of two years, commencing on 26 January 2016.
Ms. Sharapova, a 29-year-old player from Russia, provided a urine sample on 26 January 2016, after her quarter-final match at the 2016 Australian Open in Melbourne, Australia. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain meldonium, which is a metabolic modulator that is included under section S4 (Hormone and Metabolic Modulators) of the 2016 WADA Prohibited List, and therefore is also prohibited under the Programme.
Sharapova's response:
https://www.facebook.com/sharapova/posts/10153477001037680You need to know that the ITF asked the tribunal to suspend me for four years – the required suspension for an intentional violation -- and the tribunal rejected the ITF’s position.
[...]
I will immediately appeal the suspension portion of this ruling to CAS, the Court of Arbitration for Sport.